International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial

NCT02910609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-09-22

No results posted yet for this study

Summary

The three options for the treatment of patent ductus arterioles (PDA) in preterm infants are conservative approach, pharmacological intervention and surgical ligation. There is not any randomized-controlled trial that demonstrates the superiority of these approaches in preterm infants.

Conditions

  • Patent Ductus Arteriosus

Interventions

DEVICE

Echocardiography

Echocardiography is a kind of ultrasound test that shows the inner structure and functions of the heart in both groups.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Ömer Erdeve, Professor · Ankara University

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2018-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910609 on ClinicalTrials.gov